Caissa Capital Management ltd. 4
4 · Avalo Therapeutics, Inc. · Filed May 30, 2023
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common stock
2023-05-25$2.77/sh+2,000$5,540→ 1,384,700 total(indirect: See Footnote (1)) - Purchase
Common stock
2023-05-30$2.87/sh+671$1,924→ 1,385,371 total(indirect: See Footnote (1))
Holdings
- 182,300
Common stock
Footnotes (3)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $2.87, inclusive.
- [F3]These shares are directly owned by Mr. Golestaneh in his personal capacity.